Finance

Lists
BDTX:NASDAQ
Black Diamond Therapeutics Inc
US$ १.८३
+१.६७%
(+०.०३०) 1D
US$ १.९०
+३.८३% (+०.०७०)
After hours
Closed: अक्टोबर ७, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDTX...
Open
US$ १.७९
High
US$ १.८७
Low
US$ १.७८
Mkt. cap
१०.५१ करोड
Avg. vol.
५.७७ लाख
Volume
५.६३ लाख
52-wk high
US$ ४.९४
52-wk low
US$ १.६०
EPS
-US$ ०.७४
Beta
३.३२
Shares outstanding
५.७५ करोड
No. of employees
२१
Open
US$ १.७९
High
US$ १.८७
Low
US$ १.७८
Mkt. cap
१०.५१ करोड
Avg. vol.
५.७७ लाख
Volume
५.६३ लाख
52-wk high
US$ ४.९४
52-wk low
US$ १.६०
EPS
-US$ ०.७४
Beta
३.३२
Shares outstanding
५.७५ करोड
No. of employees
२१
News stories
From web sources and news partners
About Black Diamond Therapeutics Inc
CEO-
Employees२१
Founded२०१४
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to BDTX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BDTX in the last 3 months.
Highest
Current US$ १.८३
US$ १४.०० (+६६५.०३%)
Average
US$ १०.३३ (+४६४.४८%)
Lowest
US$ ८.०० (+३३७.१६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean McCutcheon
Raymond James
Buy
Maintained
US$ ११.००
+५०१.१%
08/06/2026
Maury Raycroft
Jefferies
Buy
Maintained
US$ १०.००
+४४६.४%
08/06/2026
Robert Driscoll
Wedbush
Buy
Reiterated
US$ १४.००
+६६५%
08/06/2026
Laura Prendergast
Stifel Nicolaus
Buy
Maintained
US$ ८.००
+३३७.२%
08/06/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
US$ ८.००
+३३७.२%
08/06/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ ११.००
+५०१.१%
08/06/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/05/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
EPS / Est. (USD)
-US$ ०.१७ / -US$ ०.२०
+१५.००%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
७४.३७ लाख
६२.९६ लाख
७०.०३ लाख
७३.९३ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३५.४१ लाख
३९.६६ लाख
४२.५६ लाख
४६.६४ लाख
Operating expense
१.१० करोड
१.०३ करोड
१.१३ करोड
१.२१ करोड
Total operating expenses
१.१० करोड
१.०३ करोड
१.१३ करोड
१.२१ करोड
Operating income
-१.१० करोड
-१.०३ करोड
-१.१३ करोड
-१.२१ करोड
Other non operating income
१३.१६ लाख
११.६१ लाख
१२.०० लाख
१२.३० लाख
EBT including unusual items
-८४.९८ लाख
-१.५१ करोड
-९०.३६ लाख
-९९.०५ लाख
EBT excluding unusual items
-८४.९८ लाख
-७९.१७ लाख
-९०.३६ लाख
-९९.०५ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-८४.९८ लाख
-१.५१ करोड
-९०.३६ लाख
-९९.०५ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१५
-०.१४
-०.१६
-०.१७
Interest and investment income
११.६४ लाख
११.८४ लाख
१०.२३ लाख
९.२२ लाख
Interest expense
-
-
-
-
Net interest expenses
११.६४ लाख
११.८४ लाख
१०.२३ लाख
९.२२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.०९ करोड
-१.०२ करोड
-१.१२ करोड
-१.२० करोड
Gain or loss from assets sale
-१.०० हजार
-३.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू